What is the efficacy of ranolazine for treating angina pectoris?
The efficacy of ranolazine for treating angina pectoris has been studied in numerous clinical trials. For example, the ERICA trial found that ranolazine was effective in improving exercise tolerance and reducing angina frequency when added to existing treatment with amlodipine. Other trials have also found that ranolazine is more effective than atenolol for chronic angina pectoris, and is comparable to nitroglycerin and diltiazem in terms of efficacy. Overall, ranolazine appears to be a safe and effective treatment for angina pectoris. 